EC Number   |
BRENDA No. |
Title |
Journal  |
Volume |
Pages |
Year |
Organism |
PubMed ID |
|---|
   1.14.11.16 | 684228 |
Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression |
Acta Neuropathol. |
116 |
303-315 |
2008 |
Homo sapiens |
18478238 |
| 1.14.11.16 | 695432 |
Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration |
Alcohol |
43 |
225-240 |
2009 |
Rattus norvegicus |
19393862 |
| 1.14.11.16 | 657901 |
Factor inhibiting hypoxia-inducible factor (FIH) and other asparaginyl hydroxylases |
Biochem. Soc. Trans. |
32 |
943-945 |
2004 |
Homo sapiens |
15506931 |
| 1.14.11.16 | 439255 |
Site-directed mutagenesis of residues in a conserved region of bovine aspartyl (asparaginyl) beta-hydroxylase: Evidence that histidine 675 has a role in binding Fe2+ |
Biochemistry |
35 |
3957-3962 |
1996 |
Bos taurus |
8672427 |
| 1.14.11.16 | 439253 |
The five cysteine residues located in the active site region of bovine aspartyl (asparaginyl) beta-hydroxylase are not essential for catalysis |
Biochim. Biophys. Acta |
1387 |
454-456 |
1998 |
Bos taurus |
9748662 |
| 1.14.11.16 | 764282 |
Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-beta-hydroxylase |
Bioorg. Med. Chem. |
28 |
115675 |
2020 |
Homo sapiens |
33069066 |
| 1.14.11.16 | 764397 |
Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation |
Cancer Lett. |
429 |
1-10 |
2018 |
Mus musculus |
29733964 |
| 1.14.11.16 | 439252 |
Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation |
Cancer Res. |
60 |
1261-1266 |
2000 |
Homo sapiens |
10728685 |
| 1.14.11.16 | 742226 |
Research progress of aspartyl-(asparaginyl) beta-hydroxylase in tumors |
Cancer Res. Clinic |
27 |
280-282 |
2015 |
Homo sapiens |
- |
| 1.14.11.16 | 764407 |
Aspartate beta-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1alpha/GSK3beta crosstalk |
Carcinogenesis |
41 |
1246-1252 |
2020 |
Homo sapiens |
32525968 |
